Travoprost 0.075 MG Drug Implant — RxCUI 2672088
RxNorm drug concept · Semantic clinical drug
RxCUI 2672088
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2672088
Official nameTravoprost 0.075 MG Drug Implant
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astravoprost 75 MCG Drug Implant
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)15 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Travoprost Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Travoprost is used to lower the pressure inside your eye — a condition called elevated intraocular pressure. It's prescribed for people with open-angle glaucoma or ocular hypertens...
- What is travoprost eye drops actually used for?
- Yes, and it's one of the most important things to know about this medication. Travoprost can gradually increase the amount of brown pigment in your iris — the colored part of your...
- My eye color looks like it might be changing — is that normal?
🕸️ Concept Web — How Travoprost 0.075 MG Drug Implant Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Travoprost 0.075 MG Drug Implant
RxCUI 2672088 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Travoprost
283809IN
-
Travoprost
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
IDose
2672089BN
-
IDose
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Travoprost Drug Implant
2672087SCDF -
Travoprost Drug Implant Product
2672086SCDG -
Travoprost Drug Implant [iDose]
2672092SBDF -
IDose Drug Implant Product
2672091SBDG -
Drug Implant
657710DF -
Drug Implant Product
1151136DFG
-
Travoprost Drug Implant
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Travoprost 0.075 MG
2672085SCDC -
Travoprost 0.075 MG Drug Implant [iDose]
2672093SBD -
Travoprost 0.075 MG [iDose]
2672090SBDC
-
Travoprost 0.075 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Travoprost 0.075 MG
SCDC · 2672085 -
Travoprost Drug Implant
SCDF · 2672087 -
Travoprost Drug Implant Product
SCDG · 2672086
Brand-Name Concepts
-
Travoprost 0.075 MG Drug Implant [iDose]
SBD · 2672093 -
Travoprost 0.075 MG [iDose]
SBDC · 2672090 -
Travoprost Drug Implant [iDose]
SBDF · 2672092 -
IDose Drug Implant Product
SBDG · 2672091 -
IDose
BN · 2672089
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 2672088 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 25357-0100-01 | 1 POUCH in 1 CARTON (25357-100-01) / 1 TRAY in 1 POUCH / 1... | iDose TR | Glaukos Corporation | 2023-12-13 |
| 25357-0100-99 | 1 POUCH in 1 CARTON (25357-100-99) / 1 TRAY in 1 POUCH / 1... | iDose TR | Glaukos Corporation | 2026-02-17 |
Observed labelers:
Glaukos Corporation (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7355 | Inj travoprost intra impl | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.